2021-01-11,NeuBase Therapeutics to Present at the H.C. Wainwright Virtual BioConnect Conference
2020-12-23,NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2020
2020-12-18,"NeuBase Therapeutics' CEO, Dietrich A. Stephan, Ph.D., to Present ""Accelerating the Genetic Revolution with a New Class of Synthetic Medicines"" at Tribe Public's Event on December 22, 2020"
2020-12-16,NeuBase Therapeutics Announces Positive Preclinical In Vivo Data for PATrOL-enabled Anti-gene for the Treatment of Myotonic Dystrophy Type 1
2020-12-02,"Here is What Hedge Funds Think About NeuBase Therapeutics, Inc. (NBSE)"
2020-12-02,"NeuBase Therapeutics Announces Appointment of Curt Bradshaw, Ph.D. as Chief Scientific Officer"
2020-11-23,NeuBase Therapeutics to Participate in Upcoming Investor Conferences
2020-11-18,"Did NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Insiders Buy Up More Shares?"
2020-11-17,"NeuBase Therapeutics Announces Addition of Eriks Rozners, Ph.D. and Randy Davis, MBA to Scientific Advisory Board"
2020-11-10,"NeuBase Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17"
2020-10-26,"NeuBase Therapeutics' CEO, Dietrich A. Stephan, Ph.D., to Present ""Manufacturing Heat-Seeking Missiles Against Misbehaving Genes"" at Tribe Public's Event on October 28, 2020"
2020-10-20,"Oppenheimer: These 2 Stocks Could Double, If Not More"
2020-10-13,"NeuBase Therapeutics Announces Addition of Peter Nielsen, Ph.D., Inventor of Peptide Nucleic Acid Technology, to Scientific Advisory Board"
2020-09-28,"NeuBase Therapeutics to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference on Monday, October 5th"
2020-09-17,NeuBase Therapeutics to Present at the Myotonic Dystrophy Foundation 2020 Virtual Conference
2020-09-08,NeuBase Therapeutics to Present at Upcoming Investor Conferences in September 2020
2020-08-31,(LD Micro) 360 Companies Set to Present this Week
2020-08-24,"NeuBase Therapeutics CEO, Dietrich A. Stephan, Ph.D., to Present at Tribe Publics Presentation and Q&A Webinar Event on August 26, 2020"
2020-08-20,"What Kind Of Investors Own Most Of NeuBase Therapeutics, Inc. (NASDAQ:NBSE)?"
2020-08-13,NeuBase Therapeutics Reports Financial Results for the Third Fiscal Quarter of 2020
2020-08-06,LD Micro: Announces Preliminary List of Presenters for the LD-500
2020-06-10,"Is NeuBase Therapeutics, Inc. (NBSE) A Good Stock To Buy?"
2020-05-15,"Need To Know: NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Insiders Have Been Buying Shares"
2020-04-30,NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares
2020-04-28,"NeuBase Therapeutics Announces Pricing of $31,500,000 Public Offering of Common Stock"
2020-04-27,NeuBase Therapeutics Announces Proposed Public Offering of Common Stock
2020-03-31,"NeuBase Therapeutics Announces Positive, Preclinical Data Validating its Novel Genetic Therapy PATrOL Platform"
2019-12-02,NeuBase Therapeutics Wins The Scientists Top 10 Innovations of 2019 Award for its Janus Base Technology
2019-11-25,NeuBase Therapeutics to Present at Upcoming Investor Conferences in December
2019-11-24,"NeuBase Therapeutics, Inc. (NBSE): Hedge Funds Dropped The Ball?"
2019-11-12,NeuBase Therapeutics to Present at the Stifel 2019 Healthcare Conference
2019-10-17,NeuBase Therapeutics Announces Issuance of Foundational Patent Covering the Key Building Blocks of PATrOL Enabled Therapies
2019-10-11,"NeuBase Therapeutics Announces Appointment of Cancer Biologist and RNA Therapeutics Specialist Steven Dowdy, Ph.D., to Scientific Advisory Board"
2019-09-26,NeuBase Therapeutics to Present at the Chardan 3rd Annual Genetic Medicines Conference
2019-09-21,Micro-Cap Rodeo Investor Conference October in Austin Texas
2019-09-09,NeuBase Therapeutics Hosting Key Opinion Leader Meeting on Huntington's Disease and PATrOL-Enabled Therapy on September 16th
2019-08-14,NeuBase Therapeutics Reports Financial Results for the Fiscal Third Quarter of 2019
2019-08-07,NeuBase Therapeutics to Ring the NASDAQ Closing Bell Today
2019-07-30,NeuBase Therapeutics Announces Addition of Industry Pioneer Dr. Samuel Broder and World-Renowned Geneticist Dr. George Church to Scientific Advisory Board
2019-07-24,"NeuBase Therapeutics Appoints Danith Ly, Ph.D. as Chief Scientific Officer"
2019-07-15,NeuBase Therapeutics Initiates Trading on NASDAQ Under Ticker Symbol NBSE
